Reduced platelet [3H]paroxetine binding in anorexia nervosa: Relationship to eating symptoms and personality pathology

Psychiatry Research

Volumn 142, Issue 2-3, 2006, Pages 225-232

  Bruce, Kenneth R ^a,b,c   Steiger, Howard ^a,b,c   Ng Ying Kin, N M K ^b,c   Israel, Mimi ^a,b,c  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Anorexia nervosa; Paroxetine; Personality

Indexed keywords

PAROXETINE; SEROTONIN TRANSPORTER; TRITIUM;

ADULT; ANOREXIA NERVOSA; ANXIETY; ARTICLE; BINDING AFFINITY; BINGE EATING DISORDER; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET; DIET RESTRICTION; EATING DISORDER; FEMALE; HUMAN; MENTAL INSTABILITY; PERSONALITY; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL AVOIDANCE BEHAVIOR; THROMBOCYTE ADHESION; ADOLESCENT; BULIMIA; FEEDING BEHAVIOR; LOW CALORY DIET; METABOLISM; PATHOPHYSIOLOGY; PERSONALITY DISORDER; PERSONALITY TEST; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; RADIOASSAY; STATISTICS; THROMBOCYTE;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; ANXIETY; BLOOD PLATELETS; BODY MASS INDEX; BULIMIA; DEPRESSION; DIET, REDUCING; FEEDING BEHAVIOR; FEMALE; HUMANS; PAROXETINE; PERSONALITY DISORDERS; PERSONALITY INVENTORY; PSYCHOMETRICS; RADIOLIGAND ASSAY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRITIUM;

EID: 33646853466     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2005.08.007     Document Type: Article

References (30)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), Author, Washington, DC
2. Audenaert K., Van Laere K., Dumont F., Vervaet M., Goethals I., Slegers G., Mertens J., van Heeringen C., and Dierckx R.A. Decreased 5-HT2a receptor binding in patients with anorexia nervosa. Journal of Nuclear Medicine 44 (2003) 163-169
3. Bailer U.F., Price J.C., Meltzer C.C., Mathis C.A., Frank G.K., Weissfeld L., McConaha C.W., Henry S.E., Brooks-Achenbach S., Barbarich N.C., and Kaye W.H. Altered 5-HT2A receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness. Neuropsychopharmacology 29 (2004) 1143-1155
4. Brewerton T.D., and Jimerson D.C. Studies of serotonin function in anorexia nervosa. Psychiatry Research 62 (1996) 31-42
5. Bruce K.R., Steiger H., Koerner N.M., Israel M., and Young S.N. Bulimia nervosa with co-morbid avoidant personality disorder: behavioural characteristics and serotonergic function. Psychological Medicine 34 (2004) 113-124
6. Cowen P.J., Clifford E.M., Walsh A.E.S., Williams C., and Fairburn C.G. Moderate dieting causes 5-HT2C receptor supersensitivity. Psychological Medicine 26 (1996) 1155-1159
7. Demitrack M.A., Heyes M.P., Altemus M., Pigott T.A., and Gold P.W. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders. Biological Psychiatry 37 (1995) 512-520
8. Delorme R., Betancur C., Callebert J., Chabana N., Laplanche J.-L., Mouren-Simeon M.-C., Launay J.-M., and Leboyer M. Platelet serotonergic markers as endophenotpyes for obsessive-compulsive disorder. Neuropsychopharmacology. On line publication: 31-March-2005: (2005). www.acnp.org/citations/Npp033105040348/default.pdf
9. Diaz-Marsa M., Carrasco J.L., Hollander E., Cesar J., and Saiz-Ruiz J. Decreased platelet monoamine oxidase activity in female anorexia nervosa. Acta Psychiatrica Scandinavica 101 (2000) 226-230
10. Fairburn C., and Cooper P. The Eating Disorders Examination (12th edition). In: Fairburn C., and Cooper P. (Eds). Binge Eating: Nature, Assessment and Treatment (1993), Guilford Press, New York 317-360
11. Favaro A., Caregaro L., Burlina A.B., and Santonastaso P. Tryptophan levels, excessive exercise, and nutritional status in anorexia nervosa. Psychosomatic Medicine 62 (2000) 535-538
12. Frank G.K., Kaye W.H., Meltzer C.C., Price J.C., Greer P., McConaha C., and Skovira K. Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biological Psychiatry 52 (2002) 896-906
13. Garner D.M., Olmsted M., Bohr Y., and Garfinkel P. The Eating Attitudes Test: psychometric features and clinical correlates. Psychological Medicine 12 (1982) 871-878
14. 3H]-imipramine binding. Journal of Affective Disorders 12 (1996) 267-274
15. Hadigan C.M., Walsh T.B., Buttinger C., and Hollander E. Behavioral and neuroendocrine responses to meta-CPP in anorexia nervosa. Biological Psychiatry 37 (1995) 504-511
16. Kaye W.H., Ebert M.H., Raleigh M., and Lake R. Abnormalities in CNS monoamine metabolism in anorexia nervosa. Archives of General Psychiatry 41 (1984) 350-355
17. Kaye W.H., Gwirtsman H.E., George D.T., and Ebert H. CSF-5HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain. Biological Psychiatry 23 (1988) 102-105
18. Kaye W.H., Gwirtsman H.E., George D.T., and Ebert H. Altered serotonin activity in anorexia nervosa after long-term weight recovery. Archives of General Psychiatry 48 (1991) 556-562
19. Kaye W.H., Barbarich N.C., Putnam K., Gendall K.A., Fernstrom J., Fernstrom M., McConaha C.W., and Kishore A. Anxiolytic effects of acute tryptophan depletion in anorexia nervosa. International Journal of Eating Disorders 33 (2003) 257-267 (discussion 268-70)
20. 3H-Paroxetine binding to human platelets: clues to selectivity paradox from temperature studies. British Journal of Psychiatry 96 (1985) 303-309
21. Livesley W.J., Jackson D.N., and Schroeder M.L. Factorial structure of traits delineating personality disorders in clinical and general population samples. Journal of Abnormal Psychology 101 (1992) 432-440
22. Monteleone P., Brambilla F., Bortolototti F., LaRocca A., and Maj M. Prolactin response to d-fenfluramine is blunted in people with anorexia nervosa. British Journal of Psychiatry 172 (1998) 438-442
23. O'Dwyer A.M., Lucey J.V., and Russell G.F. Serotonin activity in anorexia nervosa after long-term weight restoration: response to d-fenfluramine challenge. Psychological Medicine 26 (1996) 353-359
24. 3H]paroxetine binding in patients with eating disorders. Psychiatry Research 118 (2003) 33-38
25. Steiger H., Koerner N., Engelberg M.J., Israel M., Ng Ying Kin N.M., and Young S.N. Self-destructiveness and serotonin function in bulimia nervosa. Psychiatry Research 103 (2001) 15-26
26. Steiger H., Gauvin L., Israel M., Kin N.M., Young S.N., and Roussin J. Serotonin function, personality-trait variations, and childhood abuse in women with bulimia-spectrum eating disorders. Journal of Clinical Psychiatry 65 (2004) 830-837
27. 3H]paroxetine binding in bulimic syndromes. International Journal of Eating Disorders 37 (2005) 57-60
28. Ward A., Brown N., Lightman S., Campbell I.C., and Treasure J. Neuroendocrine, appetitive and behavioural responses to d-fenfluramine in women recovered from anorexia nervosa. British Journal of Psychiatry 172 (1998) 351-358
29. Weissman M.M., Sholomskas D., Pottenger M., Prusoff B.A., and Locke B.Z. Assessing depressive symptoms in five psychiatric populations: a validation study. American Journal of Epidemiology 106 (1977) 203-214
30. 3H]imipramine binding and serotonin uptake to platelets of adolescents suffering from anorexia nervosa. Life Sciences 38 (1986) 1235-1242